Comparison of CL Wear Between Two Allergy Drops
Information source: Hom, Milton M., OD, FAAO
Information obtained from ClinicalTrials.gov on November 03, 2008
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Allergic Conjunctivitis
Intervention: epinastine HCL and olopatadine HCL (Drug)
Phase: Phase 4
Status: Not yet recruiting
Sponsored by: Hom, Milton M., OD, FAAO Official(s) and/or principal investigator(s):
Milton M Hom, OD FAAO, Study Director, Affiliation: Private Practice
Overall contact:
Milton M Hom, OD FAAO, Phone: 6269637100, Email: eyemage@mminternet.com
Summary
Comparison of two allergy drops for enhancing comfort and performance of contact lens wear
Clinical Details
Official title: Comparison of CL Wear Between Epinastine Hydrochloride and Olopatadine Hydrochloride
Study design: Treatment, Randomized, Single Blind, Active Control, Crossover Assignment, Efficacy Study
Primary outcome: Contact lens objective and subjective clinical performance testing
Detailed description:
Contact lens patients will instill allergy drops and subjective and objective tests will be
performed
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Males or females > 18 years old
- Mild to moderate dry eye symptoms
- Likely to complete all study visits and able to provide informed consent
Exclusion Criteria:
- Current use of topical cyclosporine
- Known contraindications to any study medication or ingredients
- Active ocular diseases or uncontrolled systemic disease (blepharitis patients that are
actively being treated or disease that is uncontrollable)
- Ocular surgery within the past 3 months
Locations and Contacts
Milton M Hom, OD FAAO, Phone: 6269637100, Email: eyemage@mminternet.com
Milton M. Hom, OD, FAAO., Azusa, California 91702-2740, United States
Additional Information
Starting date: July 2007
Ending date: December 2007
Last updated: June 20, 2007
|
